PNPLA3 and hepatocellular carcinoma: The likelihood of developing HCC is higher in patients affected by NASH with cirrhosis than in patients with NAFLD [6]; an increased prevalence of HCC may be related to genetics, including the I148M variant of the PNPLA-3 gene, which represents a significant cause of mortality in NAFLD patients.